Dx Deals: Danaher Acquires StatLab in Deal Valued at More than $1 Billion
The company will fold into Leica Biosystems after the transaction closes at the end of this year
The company will fold into Leica Biosystems after the transaction closes at the end of this year
The $100 million deal will take advantage of LEX VELO technology to detect influenza and SARS-CoV-2
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
Labcorp will acquire oncology-related clinical tests services from BioReference’s parent company, OPKO Health
Recent inroads into testing of water for dialysis equipment illustrates Quest’s expanded scope with deals
Becton Dickinson divisions responsible for $3.4 billion in annual revenue are on the block
Quest Diagnostics will find out as it launches a new health coaching business that relies on lab testing, via its Pack Health subsidiary
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays
The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow